Genetically Engineered Salmon Labeling Act

I 117TH CONGRESS 1ST SESSION H. R. 270 To amend the market name of genetically altered salmon in the United States, and for other purposes. IN THE HOUSE OF REPRESENTATIVES JANUARY 11, 2021 Mr. YOUNG (for himself, Mr. DEFAZIO, and Ms. BONAMICI) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the market name of genetically altered salmon in the United States, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Genetically Engineered 4 Salmon Labeling Act’’. 5 SEC. 2. PURPOSES. 6 It is the purpose of this Act to— 7 (1) ensure that consumers in the United States 8 can make informed decisions when purchasing salm- 9 on; and 10 VerDate Sep 11 2014 05:46 Feb 05, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H270.IH H270 kjohnson on DSK79L0C42PROD with BILLS 2 •HR 270 IH (2) authorize an independent scientific review 1 of— 2 (A) the possible effects of genetically engi- 3 neered salmon on wild salmon stocks; and 4 (B) the Food and Drug Administration’s 5 approval of genetically engineered salmon for 6 human consumption. 7 SEC. 3. MARKET NAME FOR GENETICALLY ENGINEERED 8 SALMON. 9 (a) IN GENERAL.—Notwithstanding any other provi- 10 sion of law, for purposes of applying the Federal Food, 11 Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), the ac- 12 ceptable market name of any salmon that is genetically 13 engineered shall include the words ‘‘Genetically Engi- 14 neered’’ or ‘‘GE’’ prior to the existing acceptable market 15 name. 16 (b) DEFINITION.—For purposes of this section, salm- 17 on is genetically engineered if it has been modified by re- 18 combinant DNA (rDNA) techniques, including the entire 19 lineage of salmon that contain the rDNA modification. 20 SEC. 4. THIRD-PARTY REVIEW OF CERTAIN SALMON AP- 21 PROVAL. 22 The Secretary of Health and Human Services shall 23 ensure that an independent scientific organization con- 24 ducts a review of the environmental assessment that was 25 VerDate Sep 11 2014 05:46 Feb 05, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H270.IH H270 kjohnson on DSK79L0C42PROD with BILLS 3 •HR 270 IH carried out by the Food and Drug Administration in sup- 1 port of an approval of a new animal drug application re- 2 lated to AquAdvantage Salmon, dated November 12, 3 2015. 4 Æ VerDate Sep 11 2014 05:46 Feb 05, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H270.IH H270 kjohnson on DSK79L0C42PROD with BILLS